跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 21,660 条关于
“Cardiff Capital Region”
全部
21,660
临床试验
16,329
药物
180
机构
280
资讯
4,871
6个月前
Antiverse Secures $9.3M Series A to Advance AI-Powered Antibody Discovery Platform
去年
Cardiff Oncology's Onvansertib Shows Promising Results in RAS-Mutated Metastatic Colorectal Cancer Trial
去年
Cardiff Oncology Secures Second Patent for Onvansertib in Bevacizumab-Naïve mCRC Patients
2年前
Cardiff Oncology's Onvansertib Enters Phase 2 Trial for KRAS/NRAS-Mutated Metastatic Colorectal Cancer
去年
Cardiff Oncology's Onvansertib Shows Promise in Metastatic Castration-Resistant Prostate Cancer
10个月前
Cardiff Oncology Reports Positive Phase 2 Data for PLK1 Inhibitor Onvansertib in RAS-Mutated Colorectal Cancer
9个月前
Cardiff Oncology's PLK1 Inhibitor Onvansertib Shows Promise in CMML Trial and Advances Toward Phase III in Colorectal Cancer
去年
Avera Expands Cancer Research Program to Marshall, Minnesota
12年前
Wales Launches £100 Million Life Sciences Hub to Boost Innovation and Investment
6个月前
Antiverse Raises $9.3M Series A to Develop AI-Designed Antibodies for Challenging Disease Targets
第 1 页,共 488 页
上一页
下一页